Jun 14, 2024 · As we noted in last year’s report, Novo Nordisk and Eli Lilly, competing in the lucrative GLP-1 receptor agonist space that, of late, has captivated the US and beyond in weight loss, are knocking loudly on the top-10 door.Both companies, who own the highest market caps, respectively, in pharma, turned in massive growth in our latest Pharma 50.

Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.

Jan 29, 2025 · Joseph Panetta, President and CEO of Biocom California, shares his insights on biotech industry trends, policy challenges, and educational initiatives, drawing from over 25 years of leadership in California’s thriving life sciences sector.

Your advertising is all about health care. Our judges are all from health care — doctors, nurses, thought leaders, patients and more. If you want to know what impact your work has on these people and professionals, this is your chance.

Nov 2, 2023 · Lexicon Pharmaceuticals, Inc. announced that Express Scripts, the pharmacy benefit management (PBM) business of The Cigna Group's Evernorth, will be placing sotagliflozin (Inpefa) on its Basic and High Performance formularies for commercially insured patients.

In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the …

Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.

Dec 25, 2024 · Central to the Mission. Harpreet Gill, vice president of real-world solutions - project management at ICON, discussesthe progress and challenges in advancing data-driven tools and approaches in decentralized clinical trials, where ongoing education remains paramount.

Company: Elevar Therapeutics Agency: The Agency Network at MJH LifeSciences Campaign: Elevar uHCC Disease Awareness Campaign

Developments in the world of artificial intelligence continue to accelerate at a rapid pace. Our November issue of Pharmaceutical Executive explores a few of those that are starting to deliver measurable gains for the industry.